Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Other Non Operating Income (2020 - 2024)

Silo Pharma's Other Non Operating Income history spans 4 years, with the latest figure at -$2618.0 for Q3 2024.

  • For Q3 2024, Other Non Operating Income changed N/A year-over-year to -$2618.0; the TTM value through Dec 2024 reached -$14242.0, changed N/A, while the annual FY2024 figure was -$14242.0, N/A changed from the prior year.
  • Other Non Operating Income for Q3 2024 was -$2618.0 at Silo Pharma, up from -$2929.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $65888.0 in Q1 2021 and bottomed at -$198000.0 in Q2 2020.
  • The 4-year median for Other Non Operating Income is -$367.0 (2022), against an average of -$11723.9.
  • The largest YoY upside for Other Non Operating Income was 109.64% in 2021 against a maximum downside of 202.69% in 2021.
  • A 4-year view of Other Non Operating Income shows it stood at $318.0 in 2020, then crashed by 20819.5% to -$65888.0 in 2021, then soared by 99.44% to -$367.0 in 2022, then tumbled by 613.35% to -$2618.0 in 2024.
  • Per Business Quant, the three most recent readings for SILO's Other Non Operating Income are -$2618.0 (Q3 2024), -$2929.0 (Q2 2024), and -$8695.0 (Q1 2024).